Belsilver Pharma Consulting SRL
The score of Belsilver Pharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -73 % Total assets -62 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belsilver Pharma Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 88,572 € | ||||
| Equity | 18,600 € | ||||
| Cash | 55,963 € | ||||
| EBITDA | 115,479 € | ||||
| Total assets | 134,291 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
Belsilver Pharma Consulting's financial analysis
- Solvency13.9%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Belsilver Pharma Consulting
Belsilver Pharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0701.816.675
- VAT number
- BE0701816675
- Peppol
- Registered · 0208:0701816675 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Aug 2018
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Belsilver Pharma Consulting (SRL) has been based in Antwerp since 2018, active in: business and other management consultancy activities. For 2025, it reports a net profit of 88,572 € and equity of 18,600 €; its revenue is not published. Its solvency stands at 13.9%, below the median of its sector (58.4%).
Companies similar to Belsilver Pharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- NXT2 Business and other management consultancy activities Zaventem · balance sheet 134,299 €
- Section 47 Business and other management consultancy activities Schaerbeek · balance sheet 134,314 €
- AFI Consulting Business and other management consultancy activities Woluwe-Saint-Pierre · balance sheet 134,177 €
- SO What Strategy Business and other management consultancy activities Walhain · balance sheet 134,175 €
- ORDA Business and other management consultancy activities Woluwe-Saint-Pierre · balance sheet 134,169 €
- Savrola Business and other management consultancy activities Heusden-Zolder · balance sheet 134,160 €
- Acceleratr Business and other management consultancy activities Lille · balance sheet 134,438 €
- Trio Consulting Business and other management consultancy activities Beveren-Kruibeke-Zwijndrecht · balance sheet 134,446 €
Frequently asked questions about Belsilver Pharma Consulting
What is the revenue of Belsilver Pharma Consulting?
Belsilver Pharma Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Belsilver Pharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0701816675 for Belsilver Pharma Consulting, if the company is VAT-registered. Its company number (CBE) is 0701.816.675.
Where is the registered office of Belsilver Pharma Consulting?
According to the CBE register, the registered office of Belsilver Pharma Consulting is in 2610 Antwerp.
What is the equity of Belsilver Pharma Consulting?
At the close of the 2025 financial year, the equity of Belsilver Pharma Consulting amounts to 18,600 €, a solvency of 13.9% of total assets.
Who manages Belsilver Pharma Consulting?
The register lists 1 active mandates at Belsilver Pharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belsilver Pharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →